A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety.

Adolescent Weight Management Study

NCT00212173 ·Status: COMPLETED ·Phase: NA

A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.

NCT00234988 ·Status: COMPLETED ·Phase: PHASE4

Sibutramine-metformin Combination Versus Sibutramine and Metformin Monotherapy in Obese Patients

NCT00941382 ·Status: UNKNOWN ·Phase: PHASE3

A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects

NCT00134199 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese Patients

NCT00234832 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)

NCT00533481 ·Status: COMPLETED ·Phase: PHASE2

A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight

NCT05209984 ·Status: WITHDRAWN ·Phase: PHASE3

Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity

NCT00330525 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2)

NCT04897412 ·Status: COMPLETED ·Phase: PHASE2

Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity

NCT05713799 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat

NCT07140939 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Weight Loss Study in Overweight Men and Women

NCT00993421 ·Status: TERMINATED ·Phase: PHASE2

A Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Obese Children Aged 7 to 11 Years

NCT02696148 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat

NCT05736107 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of 10XB-101 in Adults With Bilateral Flank Adiposity

NCT05760248 ·Status: COMPLETED ·Phase: PHASE2

A Study of Tirzepatide (LY3298176) in Pediatric Participants With Obesity

NCT05696847 ·Status: COMPLETED ·Phase: PHASE1

Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity

NCT02918279 ·Status: COMPLETED ·Phase: PHASE3

Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures Study

NCT01032889 ·Status: COMPLETED ·Phase: PHASE2

Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/topiramate in Overweight Comorbidities/obesity

NCT05209997 ·Status: WITHDRAWN

A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 Years

NCT01789086 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

NCT06858839 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Phase 2b Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat.

NCT06005441 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Sibutramin-containing Drugs in Patient With Alimentary Obesity

NCT05821543 ·Status: COMPLETED ·Phase: PHASE4

A Dose-ranging, Study of the Safety and Efficacy of Subcutaneous Injections of LIPO-102 Compared With Placebo for the Reduction of Abdominal Subcutaneous Adiposity

NCT01180465 ·Status: COMPLETED ·Phase: PHASE2

One-Year Study of S1B-509 vs Placebo for Weight Loss

NCT06517797 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2